Skip to content

We are accredited to the Patient Information Forum (PIF) TICK Quality Mark >. This confirms that our SMA-related information has been through a professional and thorough production process and is based on reliable, up-to-date evidence which is communicated clearly.

If you would like to be involved as a contributor or reviewer, we would be delighted to hear from you; please email information@smauk.org.uk
Last updated: October 2025

Though the NHS website provides information about Spinal Muscular Atrophy (SMA), it is at a more generic level than a parent with a child diagnosed with the condition or a young person or adult living with SMA may be looking for. The NHS website recognises this and signposts our website for this more ‘in-depth’ information.

We are also often a first port of call for information sought by members of the public who want to find out more about the condition and ‘Google’ SMA. Professionals new to the condition who are in a support role to someone affected by SMA also often turn to us for information and advice.
In summary, therefore, we aim to maintain and further develop user-friendly accessible information for:

  • People affected by SMA

Information that:

    • Tells them about the condition, its management, services available, any treatment options and research updates
    • Enables them to communicate effectively with medical and other professionals and play an active role in care, treatment and decision making, for themselves or their children.

  • Professionals who are new to the condition and / or in a support role.

Information that:

    • Enables them to quickly understand the nature of the condition and the challenges that are faced
    • Tells them about service and support options and research and treatment updates

  • The general public who want to find out about the condition

The PIF TICK is the UK-wide Quality Mark for Health Information.

When you see the PIF TICK on leaflets, websites, apps or videos it shows an organisation’s health information has been through a professional and robust production process. To be awarded the PIF TICK an organisation must show its health information production process meets 10 criteria:

  1. Systems:  Information is created using a consistent and documented  process.
  2. Training: Staff receive ongoing training and support.
  3. Need: Resources meet a genuine need.
  4. Evidence: Information is based on reliable, up-to-date evidence which is communicated clearly.
  5. Involving users: Users are involved in the development of information.
  6. Health inequalities: Information is written to meet health and digital literacy, language and accessibility needs of the target audience.
  7. Transparency and legal: Content is clear, easy to access, and meets local legal requirements.
  8. Feedback: There is a clear process for users to provide feedback.
  9. Disseminating: Information is promoted to maximise reach.
    Impact: The impact of information is measured.
  10. Impact: the impact is measured.

For more detail see: PIF TICK Criteria at a Glance 2024 >

From 2012 – 2020, SMA UK was accredited to the Information Standard (an NHS England quality standard with similar aims to PIF tick). This was phased out. SMA UK was first accredited to the PIF Tick quality standard in July 2021 and is audited annually.

We are accredited members of the Patient Information Forum >. When you see the PIF Tick on one of our information resources you know that it has been produced in the following way:

Our Information Production System >

These are reviewed by experts in SMA and members of the various Target Audiences. These publications carry the PIF TICK >.

Written Publications

  • All publications are reviewed annually to ensure any contact details and links are correct.
  • An interim review is conducted if information needs updating e.g. if there is new treatment information.
  • A full review is conducted once every three years.

Treatment & Care Webinars with Experts

  • These have a latest review date of 3 years
  • If there are changes to treatment and care that mean a webinar is no longer sufficiently up to date, it is taken down.
Current Title Publication Date & Version
Spinal Muscular Atrophy – A Brief SummaryMay 2026

V12
About SMA (trifold leaflet)November 2024

V3
What is 5q Spinal Muscular Atrophy?May 2026

V17
Symptoms, Diagnosis & Effects of 5q SMA

-Type 1
-Type 2
-Type 3
-Type 4
May 2026

V6
Summary of the Genetics of 5q Spinal Muscular AtrophyJuly 2025

V2
The Genetics of 5q Spinal Muscular AtrophyJuly 2025

V8
Family Planning for Couples Affected by 5q SMAMay 2026

V14
Drug treatments for children who have 5q SMA – England, Wales Northern IrelandJune 2026

V2
Drug treatments for children who have 5q SMA – ScotlandMay 2026

V2
Drug treatments for adults who have 5q SMAJuly 2026

V3
Hearing Your Baby’s Diagnosis of Spinal Muscular Atrophy (SMA)June 2025

V3
Hearing Your Child’s Diagnosis of Spinal Muscular Atrophy (SMA)June 2025

V3
SMA Type 1 – Looking After Your Child who has had a Recent DiagnosisAugust 2026

V23
SMA Type 2 – Looking After Your Child who has had a Recent DiagnosisAugust 2026

V18
Toys, Play & Activities for Babies and Young Children who have SMAOctober 2025

V7
SMA Type 3 – Looking After Your Child who has had a Recent DiagnosisAugust 2026

V14
Spinal Muscular Atrophy: Our SMArt WorldMarch 2026

V2
5qSMA – Information for schoolsOctober 2025

V6
Essential Information for Emergency Services when Assessing and Caring for a Child who has Spinal Muscular AtrophyAugust 2026

V2
Adult Onset SMA – Diagnosis and CareJuly 2026

V12
Who’s Who of ProfessionalsJune 2025

V8
The Inheritance Patterns of Some Rarer Forms of SMASept 2025

V6
Rarer Form: DSMA – VJanuary 2025

V3
Rarer Form: SBMAJanuary 2025

V2
Rarer Form: SMA – LEDJanuary 2025

V2
Rarer Form: SMA – PMEJanuary 2025

V2
Rarer Form: SMARD1January 2025

V5
Rarer Form: X – linked SMAJanuary 2025

V3
SMA Newborn Screening Test – Helping you decideMarch 2026

V1
Hearing your baby’s newborn bloodspot test shows ‘suspected SMA’March 2026

V1
If your area is not part of the In Service Evaluation for SMAMarch 2026

V1
Testing for 5q SMA during pregnancyMarch 2026

V1
Treatment during pregnancy of a baby diagnosed with SMA Type 1April 2026

Webinar

 

You can find all these on our website. If you would like to order any copies please fill out this order form Information Publications Order Form >

We work with a supportive and connected SMA Community who provide tips, ideas and share their experiences. These may be published as:

Podcasts / Videos >  and Written pieces >

We take care to ensure their accuracy if, for example, they contain any condition specific information. They do not carry the PIF TICK.

Core Team (Staff)
Information Lead Accountable for the delivery and overall quality of health and care information production. Responsible for system review and monitoring. Drafts publications working with appropriate HESCPs / community members. Reviews Expert and Target audience (TA) feedback & jointly with appropriate other team members makes decisions re: final product.
SMA Care UK Project ManagerWorking with appropriate HCPs from the project drafts publications for the SMA Community about any newly agreed standards of care. Reviews Target audience (TA) feedback & jointly with appropriate project members makes decisions re: final product.
Members of the Community Support, Advocacy and Community Engagement TeamsContent development advice, Expert Review and / or Target Audience Review
Scientific Research CorrespondentsWriting / Expert review
External Health, Education and Social Care professionals (HESCPs)Expert Review or Target Audience Review.
People living with / affected by SMAContent / format development, Target Audience Review and / or Expert Review
Members of the public with no connections with SMATarget Audience Review

Many people contribute to our information service in one or more ways, including giving expert and target audience feedback, sharing ideas, tips, experiences and photos and by asking questions. We’re extremely grateful to all the members of the SMA Community and the health, education and social care professionals who give their time, experience and expertise.

If you would like to be involved as a contributor or reviewer, we would be delighted to hear from you; please email information@smauk.org.uk